INTRODUCTION AND OBJECTIVES:
Usually, kidney cancer with cavoatrial extension is managed with cardiopulmonary by-pass (CBP) and deep hypothermia circulatory arrest (DHCA).In this study, we aim to report the feasibility, safety and effectiveness of radical nephrectomy with cavoatrial thrombectomy on normothermic CPB and beating heart. METHODS: Through a laparotomic median incision, the urological equipe mobilised the colon and exposed the kidney. The renal vascular pedicle was exposed and the radical nephrectomy with adrenalectomy was performed. The right or left renal veins, that were obstructed by neoplastic thrombus (NT), were isolated. The liver was mobilized to allow the exposition of the intra and supra hepatic inferior vena cava (IVC), completely occupied by the NT. Sternotomy and pericardiothomy were performed by the heart surgery equipe. Aortic arch, superior VC and the IVC just above iliac veins were cannulated. On normothermic CBP and beating heart, right atriotomy and a "J" incision on IVC were simultaneously performed. At the same time, the heart surgeons and urologists removed the NT from the right atrium (RA) and pulmonary artery (PA), the left or right renal vein (RV) and the IVC. The IVC wall was resected only if infiltrated by the thrombus. RA and IVC were closed and the patient was weaned from CBP. RESULTS: We treated 8 patients (pts; range 51-74 yrs) affected by renal tumor with a NT extended from the right (3 pts) or the left (4 pts) RV to all IVC and to the RA. The diagnosis was incidental in 3 pts. One pt had a previously cardio-pulmunar by-pass. In one case the thrombus partially involved the right supra hepatic veins and the left renal vein; in other patient the thrombus jutted out a right branch of PA. Distant metastasis were detected in 3 pts. A significant coronary disease was diagnosed in 1 patient and was contemporarily resolved with CABG.Median CPB time: 113 min (range 40-240); Surgical time: 380 min (range 360-440). Estimated blood loss 800 ml (range 300-2000). Autologous blood transfusion: 700 ml (range 500-1000)Intensive care stay: 4 days (range 1-7). Post operative in-hospital stay: 9,5 days (range 7-20). Post operative complications: atrial fibrillation in 1 case; anaemia in 1 case treated with blood transfusion; intestinal ischemia in 1 pt with nodal involvement of mesenteric artery and who died one day after surgery. A post-surgical transthoracal echocadiography demonstrated regular parameters without any residual thrombus in RA and normal cardiac function in all pts. The 1-month post operative total body CT showed a regular IVC with no signs of persistent disease.The median CSS was 23 months (range 7-38).
CONCLUSIONS: In our experience, management of T3c kidney cancer with a beating heart normothermic CBP appears a feasible, safe and effective technique. As neither hypothermia nor heart arrest are needed, our technique improves patient recovery and reduces risks for complications. Furthermore, with cannulation of lower IVC, other vascular access for lower venous return are not necessary. METHODS: Thirty-five consecutive patients with renal tumor and IVC thrombus were treated between July 2011 and September 2016. Baseline, perioperative and follow-up data were collected into prospectively maintained IRB approved databases. Key steps of surgery include: a meticulous isolation of IVC; the isolation and sealing of all lumbar and collateral vessels, a full monolateral retroperitoneal dissection for staging purpose and to have a complete control of IVC; isolation of left renal vein, Tourniquet placement and infrarenal IVC control. IVC incision and thrombectomy; cava suture with 3/0 visi-black monocryl or 5/0 goretex; restoration of IVC flow; nephrectomy. We report perioperative and oncologic outcomes of 35 consecutive patients treated in two tertiary referral centers.
Source of
RESULTS: All procedures were successfully completed; open conversion was necessary in one case (2.8%). Median operative time was 300 minutes. Twenty-one patients (68.6%) did not experience any complication. Ten patients (28.6%) required blood transfusion (Clavien grade 2); one patient (2.8%) had a Clavien grade 3a complication (gastroscopy); two patients (5.7%) had Clavien grade 3b complications (reintervention due to bleeding from adrenal gland and subphrenic ascess requiring drainage, respectively); one patient (2.8%) experienced a PRESS syndrome requiring ICU admission (Clavien 4a). Out of 13 patients who underwent cytoreductive nephrectomy and IVC thrombectomy, only one patient died of disease progression 14 months postoperatively. Both 2-yr cancer specific and overall survival rates in this subpopulation were 88.9%. Twenty-two patients received surgery with curative intent and 5 of these experienced disease recurrence: 2-yr metastasis free, cancer specific and overall survival rates were 56%, 100% and 94.4%, respectively.
CONCLUSIONS: Robotic IVC thrombectomy is a challenging surgical procedure. In tertiary referral centers this procedure is feasible, safe and associated with favorable perioperative outcomes and encouraging short term oncologic outcomes.
